Read Larry Connors' blog – Short Term Trading Strategies
"Even as individual regions see dramatic ups and downs quarter over quarter, overall international investments have been steady in 2009," said Jessica Canning, director of global research for Dow Jones VentureSource. "This overall consistency is a promising sign as investors chart their course after the global downturn in 2008."
In the U.S., venture investors put $5.1 billion into 616 deals, a slight drop from the second quarter and a 38% decrease from one year ago.
Investment in Europe* Recovers After Record Low In 2Q
According to Dow Jones VentureSource, Europegarnered $998 million (*730 million) in 201 deals during the third quarter of 2009, up 23% from the previous quarter which was the lowest on record since Dow Jones VentureSource began reporting on the region in 2000. The third quarter's total is still a 48% drop from the $1.9 billion invested in 312 deals during the same period last year.
"In Europe, the lag in the liquidity and fundraising markets has investors spending less, but spending wisely," said Arno Castanet, a research manager in Dow Jones VentureSource's Londonoffice. "In Information Technology, investors are putting more capital to work in the Web-heavy Information Services sector and in Healthcare they're favoring medical devices."
The Information Technology (IT) industry attracted the largest proportion of investment with $425 million (*311 million) invested in 87 deals in the third quarter, down 30% from the same period last year. Investment in the Web-heavy Information Services sector carried the IT industry as investors put $173 million (*127 million) to work in 22 deals. Meanwhile, the Software sector hit a record low with just $72 million (*52 million) invested in 35 deals this quarter.
Investors put $296 million (*216 million) into 41 Healthcare deals in Europeduring the most recent quarter, a 41% decline from the same period last year. For the first time, the Medical Devices sector attracted more capital than Biopharmaceuticals as investors put $158 million (*116 million) into 21 medical device deals and $122 million (*89 million) into 18 biopharmaceuticals deals.
Europe's Energy and Utilities industry was up 114% from the previous quarter, with $144 million (*106 million) invested in 22 deals. The industry, however, is still down 54% from a year ago. In the third quarter, all investments in Energy and Utilities went to companies in the Renewable Energy sector.
Deals Sizes Shrink Worldwide
According to the data, the size of venture deals has decreased around the world since 2008. In Europe, the median size of a venture capital deal dropped 30% from $3.7 million (*2.5 million) in the third quarter of 2008 to $2.6 million (*1.9 million) in the most recent quarter. While the median in Israelis now $5.2 million, a 31% decrease from 2008, it has steadily risen every quarter since the first quarter of 2009, a promising trend for investors and their companies.
The median sizes of deals in Indiaand Canadastood at $3.6 million and $4.2 million, respectively, year-to-date. In China, the median deal size was $7.4 million after the first nine months of 2009.
The median deal size in the U.S.dropped from $7 million a year ago to $5 million in the most recent quarter.
Further Country Perspectives
The second-favorite destination for venture capital, behind the U.S., the United Kingdomsaw $393 million (*288 million) put into 67 deals during the third quarter. This is on par with the $419 million (*284 million) put into 83 deals during the same period last year.
Despite a 41% drop from the same period last year, Mainland Chinahad its strongest quarter of 2009 as $465 million went into 40 venture deals during the third quarter. Notably, the country's business and financial services sector captured the most dollars with $155 million put into eight deals.
Francehad its worst quarter of 2009 and dropped 58% from the same period last year as venture investors put $173 million (*126 million) into 55 deals.
Israel-based companies garnered $191 million in 29 venture deals, 57% less than the $449 million invested in 48 deals during the same period in 2008.
In Switzerland, investors put $80 million (*59 million) into seven deals, on par with the previous quarter but down 37% from a year ago.
In India, venture capitalists invested $81 million in 14 deals in the third quarter, a staggering 70% less than the $274 million invested in 31 deals last year.
Capital investment in Germanyplummeted to $74 million (*54 million), down from $282 million (*192 million) a year ago.
On par with the previous quarter, Canadagarnered $115 million in venture capital with 13 deals completed in the third quarter. This is still a 48% drop from the $221 million put into 25 deals in the third quarter of 2008.
Swedenhad its best quarter of 2009 though venture investment was down 22% from one year ago. Capital investment in the country was $75 million (*55 million) in the most recent quarter.
*All Europeinvestment figures based on weighted conversion rates of 1.47134 (2008) and 1.36685 (2009). All percentages were calculated using USD.
About Dow Jones VentureSource's Research Methodology
The investment figures included in this release were collected by surveying professional venture capital firms, through in-depth interviews with portfolio company CEOs and CFOs, and from a number of secondary sources. These statistics represent equity investments into early-stage, innovative companies only and do not include companies receiving funding solely from corporate, individual, and/or government investors, or from buyout or other non-VC investment firms. For more information on our methodology, visit http://www.fis.dowjones.com/VS/VentureSourceFAQ.html.
For general information about VentureSource, visit http://venturecapital.dowjones.com.
No statement herein is to be construed as a recommendation to buy or sell securities or to provide investment advice.
Copyright 2009, Dow Jones VentureSource
About Dow Jones
Dow Jones & Company is a subsidiary of News Corporation (NASDAQ: NWS, NWS.A; ASX: NWS, NWSLV; www.newscorp.com). Dow Jones is a leading provider of global business news and information services. Its Consumer Media Group publishes The Wall Street Journal, Barron's, MarketWatch and the Far Eastern Economic Review. Its Enterprise Media Group includes Dow Jones Newswires, Factiva, Dow Jones Client Solutions, Dow Jones Indexes and Dow Jones Financial Information Services. Its Local Media Group operates community-based information franchises. Dow Jones owns 50% of SmartMoney and 33% of Stoxx Ltd. and provides news content radio stations in the U.S.
CONTACT: Kim Gagliardi, Dow Jones & Company Tel: +1 603 864 8873 e-mail: kimberly.gagliardi@dowjones.com Michael Burns, Dow Jones & Company Tel: +44 (0)203 5434 (Europe & EMEA) e-mail: michael.burns@dowjones.com Joe Spitzer, Dow Jones & Company Tel: +852 2831 6482 (AsiaPacific) e-mail: joe.spitzer@dowjones.com WWW: http://www.dowjones.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
